InsiderTrades.com logo
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.

CING Insider Trading

Insider Ownership Percentage: 38.43%
Insider Buying (Last 12 Months): $1,013,907.50
Insider Selling (Last 12 Months): $0.00

Cingulate Insider Trading History Chart

This chart shows the insider buying and selling history at Cingulate by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cingulate Share Price & Price History

Current Price: $0.88
Price Change: ▲ Price Increase of +0.04 (4.76%)
As of 04/26/2024 01:00 AM ET

This chart shows the closing price history over time for CING up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.

Cingulate Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2024Jennifer L CallahanCFOBuy55$27.10$1,490.502,333View SEC Filing Icon  
9/15/2023Jennifer L CallahanInsiderBuy250$13.40$3,350.002,275View SEC Filing Icon  
8/11/2023Peter J WerthDirectorBuy91,157$11.00$1,002,727.00139,916View SEC Filing Icon  
5/15/2023Jennifer L CallahanInsiderBuy100$20.20$2,020.002,025View SEC Filing Icon  
5/12/2023Jennifer L CallahanInsiderBuy200$21.60$4,320.001,925View SEC Filing Icon  
12/16/2022Shane J SchafferCEOBuy500$20.40$10,200.002,075View SEC Filing Icon  
12/14/2022Jennifer L CallahanInsiderBuy377$19.80$7,464.601,725View SEC Filing Icon  
12/13/2022Peter J WerthDirectorBuy1,446$19.60$28,341.6048,758View SEC Filing Icon  
12/13/2022Shane J SchafferCEOBuy86$20.20$1,737.20911View SEC Filing Icon  
11/28/2022Jennifer L CallahanInsiderBuy174$19.60$3,410.401,271View SEC Filing Icon  
11/23/2022Craig S GilgallonEVPBuy178$16.80$2,990.40477View SEC Filing Icon  
11/23/2022Laurie MyersCOOBuy55$18.00$990.002,413View SEC Filing Icon  
11/22/2022Gregg Wm GivensDirectorBuy4,250$17.60$74,800.007,715View SEC Filing Icon  
9/8/2022Jennifer L CallahanInsiderBuy175$30.00$5,250.001,097View SEC Filing Icon  
9/6/2022Peter J WerthDirectorBuy3,725$30.40$113,240.0047,311View SEC Filing Icon  
6/1/2022Laurie MyersCOOBuy10$23.60$236.002,335View SEC Filing Icon  
5/17/2022Laurie MyersCOOBuy10$24.20$242.002,325View SEC Filing Icon  
5/6/2022Curtis MedeirosDirectorSell876$25.40$22,250.40View SEC Filing Icon  
3/17/2022Peter J WerthDirectorBuy1,350$35.80$48,330.00View SEC Filing Icon  
3/16/2022Jennifer L CallahanInsiderBuy95$27.80$2,641.00View SEC Filing Icon  
3/16/2022Laurie MyersCOOBuy17$28.00$476.00View SEC Filing Icon  
3/14/2022Craig S GilgallonEVPBuy298$27.60$8,224.80View SEC Filing Icon  
3/14/2022Gregg Wm GivensDirectorBuy450$26.40$11,880.00View SEC Filing Icon  
3/14/2022Horn Louis G VanCFOBuy750$26.80$20,100.00View SEC Filing Icon  
3/14/2022Jennifer L CallahanInsiderBuy600$29.20$17,520.00View SEC Filing Icon  
See Full Table
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.

SEC Filings (Institutional Ownership Changes) for Cingulate (NASDAQ:CING)

41.31% of Cingulate stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CING by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cingulate Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Armistice Capital LLC754,792$0.54M0.0%N/A4.820%Search for SEC Filing on Google Icon
10/23/2023Commonwealth Equity Services LLC100,771$71K0.0%N/A0.643%Search for SEC Filing on Google Icon
5/5/2023Prime Capital Investment Advisors LLC48,262$48K0.0%N/A0.413%Search for SEC Filing on Google Icon
11/8/2022Eagle Asset Management Inc.107,527$0.12M0.0%+124.5%0.951%Search for SEC Filing on Google Icon
5/12/2022Eagle Asset Management Inc.47,895$94K0.0%N/A0.424%Search for SEC Filing on Google Icon
5/5/2022Lynwood Capital Management Inc.225,994$0.45M0.5%+80.8%1.998%Search for SEC Filing on Google Icon
2/14/2022Altium Capital Management LP83,931$0.23M0.1%N/A0.742%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cingulate logo
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders intended for children, adolescents, and adults. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
Read More on Cingulate

Today's Range

Now: $0.88
Low: $0.84
High: $0.93

50 Day Range

MA: $1.07
Low: $0.79
High: $1.35

52 Week Range

Now: $0.88
Low: $0.75
High: $23.40

Volume

8,653 shs

Average Volume

306,203 shs

Market Capitalization

$4.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Cingulate?

Cingulate's top insider investors include:
  1. Peter J Werth (Director)
  2. Gregg Wm Givens (Director)
  3. Laurie Myers (COO)
  4. Jennifer L Callahan (CFO)
  5. Jennifer L Callahan (Insider)
  6. Shane J Schaffer (CEO)
  7. Craig S Gilgallon (EVP)
  8. Curtis Medeiros (Director)
Learn More about top insider investors at Cingulate.
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.